Overview

A Study to Assess How Itraconazole Affects the Uptake and Elimination of Capivasertib in the Body

Status:
Completed
Trial end date:
2021-03-25
Target enrollment:
Participant gender:
Summary
This study will be an open-label, fixed sequence study in healthy subjects (vasectomized males and females of non-childbearing potential), performed at a single study centre.
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca
Collaborator:
Parexel
Treatments:
Itraconazole